Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Vectura Slides On Asthma Treatment Failure

Mon, 26th Nov 2018 10:49

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------John Wood Group, up 5.1%. HSBC raised the oilfield services company to Buy from Hold. ----------FTSE 100 - LOSERS----------Melrose Industries, down 4.5%. Sky News reported the industrial turnaround specialist is mulling its options after receiving some disappointing bids for its acquired business GKN's Powder Metallurgy unit. Melrose, which took control of GKN in April after an acrimonious hostile takeover bid, has previously said it was exploring strategic options for the unit. Sky said it has learnt Melrose executives are deciding whether to go ahead with an immediate auction of GKN Powder Metallurgy following initial bids last week valuing the unit at around GBP1.60 billion. Sky said this figure was beneath analyst forecasts that the unit would command a price tag of GBP2 billion, and this has raised questions over whether Melrose could halt the sale process. The news agency reported that sources said Apollo and PAI Partners were among the private equity firms which tabled offers last week.----------Rio Tinto, down 0.2%. The Anglo-Australian miner said it sold its majority stake in a uranium mine in Namibia for up to USD106.5 million to China National Uranium Corp as it continues to focus on its core assets. The miner has agreed to sell its 69% stake in Rossing Uranium Ltd - which owns the Rossing mine - for an initial USD6.5 million in cash on completion. A further USD100 million contingent consideration is payable following completion, linked to uranium spot prices over the next seven years. Rio also will receive a cash payment if China National Uranium sells the Zelda 20 mineral deposit during an unspecified restricted period after completion of the deal. The maximum consideration cap for the deal, however, will be USD106.5 million. The deal remains subject to regulatory approval in Namibia. The transaction is expected to complete in the first half of 2019.----------FTSE 250 - WINNERS----------Premier Oil, up 8.3%, Tullow Oil, up 4.7%, Petrofac, up 4.1%. The oil stocks were tracking spot oil prices higher quoted at USD60.04 a barrel from USD58.78 late Friday. "The rebound in oil prices ahead of next week's OPEC meeting and a possible production cut has helped boost oil and oilfield services providers," said CMC Markets analyst Michael Hewson. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Anglesey Mining, up 53%. The miner said it stuck an agreement with QME Mining Technical Services on a project development and cooperation agreement around the Parys Mountain copper, zinc, lead, gold and silver project in Wales. QME will carry out a programme of design, engineering and optimisation studies related to Parys Mountain future development. The objective of the study is to determine an optimum development plan for the project, using all means of accessing both inferred and indicated resources. On the completion of the optimisation study, Anglesey will award QME contracts for the development of the decline and underground mine, including the rehabilitation of the shaft.----------Faroe Petroleum, up 25% at 152.00 pence. The North Sea-focused oil and gas firm faced a hostile takeover bid from major shareholder DNO, as the Norwegian firm made a GBP608 million offer directly to fellow investors. DNO - which already has a 28% stake in Faroe - made a 152 pence per share cash takeover offer, valuing Faroe at GBP607.9 million. The offer price represents at 45% premium to the 105 pence share price before its initial share purchase in April and 21% higher than Faroe's 125.8 pence share price at the close on Friday. In response to the takeover bid, Faroe Petroleum said the Norwegian firm did not engage with the company before announcing its offer, and Faroe's board now will meet with its advisers to consider the DNO offer. In the meantime, Faroe urged shareholders to take no action in relation to the DNO bid. ----------Intercede Group, up 21%. The authentication software firm said it is confident in returning to profit in its next financial year as it reported a significantly narrowed loss in the first half of its current 2019 financial year. Intercede said its pretax loss narrowed in the six months to the end of September to GBP823,000 from GBP3.3 million loss reported for the same period in 2017. Revenue rose by 14% to GBP4.2 million from GBP3.7 million, on increasing number of orders from both new and existing customers. Meanwhile, operating expenses reduced by 29% to GBP4.7 million, as the company initiated the cost-cutting review in the second half of its prior financial year.----------OTHER MAIN MARKET AND AIM - LOSERS----------Vectura Group, down 8.1%. The respiratory medicine maker's shares were lower after it reported failure of its VR475 phase three study. VR475 is a device consisting of budesonide delivered by Vectura's nebuliser inhalation system and is designed to treat patients with asthma. The results from the study indicated a trend in the reduction of the rate of clinically significant exacerbations among patients receiving either 1 milligram or 0.5 milligrams doses, taken twice daily during a 52-week period. However, the results did not reach statistical significance. The open label arm study - meaning with full transparency with the patient - using a conventional nebuliser, a drug delivery device, failed to reach statistical significance against the placebo. Financially, VR475 will be fully impaired for 2018, making a negative impact on Vectura's pretax line of GBP40 million. In 2017, Vectura reported a pretax loss of GBP102.2 million.----------

More News
1 Oct 2021 10:22

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

Read more
29 Sep 2021 09:23

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

(Adds background)LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British supermarket Morrisons will be decided at an auction on Saturday, when two U.S. private equity groups will go head-to-head in up to five rounds of bids.Britain's Takeover...

Read more
20 Sep 2021 13:35

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

Read more
16 Sep 2021 11:29

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

Read more
16 Sep 2021 09:07

TOP NEWS: Vectura shareholders accept Philip Morris takeover

TOP NEWS: Vectura shareholders accept Philip Morris takeover

Read more
16 Sep 2021 08:02

Philip Morris seals contentious Vectura takeover

(Sharecast News) - Philip Morris International has taken control of Vectura after the cigarette company's contentious bid was supported by owners of almost 75% of the inhaler maker's shares.

Read more
16 Sep 2021 07:33

UPDATE 3-Philip Morris seals deal for UK's Vectura despite health group concerns

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds comment from health group; background on deal)By Pushkala Aripaka and Siddh...

Read more
16 Sep 2021 07:33

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds detail, background)By Pushkala AripakaSept 16 (Reuters) - Cigarette maker P...

Read more
14 Sep 2021 18:24

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

Read more
8 Sep 2021 07:49

UPDATE 3-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds detail, shares)By James DaveyLONDON, Sept 8 (...

Read more
8 Sep 2021 07:49

UPDATE 2-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds details, shares)By James DaveyLONDON, Sept 8 ...

Read more
8 Sep 2021 07:28

UPDATE 2-UK's Smiths to sell medical division to ICU for $2.4 bln, snubs TA

* Smiths Group agrees sale of unit to ICU Medical* Withdraws recommendation for TA Associates deal* Shares up 4%, biggest riser on the FTSE 100 index (Adds shares, ICU Medical statement, background)By Yadarisa ShabongSept 8 (Reuters) - British indus...

Read more
19 Aug 2021 14:32

Philip Morris snaps up more Vectura shares ahead of deal deadline

(Sharecast News) - US tobacco giant Philip Morris has bought up more shares of London-listed inhaler maker Vectura.

Read more
19 Aug 2021 10:47

Philip Morris lifts Vectura stake to 29%, halts further market trades

Philip Morris lifts Vectura stake to 29%, halts further market trades

Read more
18 Aug 2021 10:27

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.